TEST BANK n
Basic and Clinical Pharmacology by Bertram Katzung
n n n n n n
15th Edition
n
,TEST BANK
n
, Test nBank nFor nBasic nand nClinical nPharmacology n15th nEdition nby nBertram nKatzung
Table nof nContents:
Section nI: nBasic nprinciples
Chapter n1: nIntroduction: nthe nnature nof ndrugs n& ndrug ndevelopment n& nregulation
Chapter n2: nDrug nreceptors n& npharmacodynamics
Chapter n3: nPharmacokinetics n& npharmacodynamics: nrational ndosing n& nthe ntime ncourse
nof ndrug naction
Chapter n4: nDrug nbiotransformation
Chapter n5: nPharmacogenomics
Section nII: nAutonomic ndrugs
Chapter n6: nIntroduction nto nautonomic npharmacology
Chapter n7: nCholinoceptor-activating n& ncholinesterase-inhibiting ndrugs
Chapter n8: nCholinoceptor-blocking ndrugs
Chapter n9: nAdrenoceptor nagonists n& nsympathomimetic ndrugs
Chapter n10: nAdrenoceptor nantagonist ndrugs
Section nIII: nCardiovascular-renal ndrugs
Chapter n11: nAntihypertensive nagents
Chapter n12: nVasodilators n& nthe ntreatment nof nangina npectoris
Chapter n13: nDrugs nused nin nheart nfailure
Chapter n14: nAgents nused nin ncardiac narrhythmias
Chapter n15: nDiuretic nagents
Section nIV: nDrugs nwith nimportant nactions non nsmooth nmuscle
Chapter n16: nHistamine, nserotonin, n& nthe nergot nalkaloids
Chapter n17: nVasoactive npeptides
Chapter n18: nThe nEicosanoids: nprostaglandins, nthromboxanes, nleukotrienes, n& nrelated
ncompounds
Chapter n19: nNitric noxide
Chapter n20: nDrugs nused nin nasthma
Section nV: nDrugs nthat nact nin nthe ncentral nnervous nsystem
Chapter n21: nIntroduction nto nthe npharmacology nof ncns ndrugs
Chapter n22: nSedative-hypnotic ndrugs
Chapter n23: nThe nAlcohols
Chapter n24: nAntiseizure ndrugs
Chapter n25: nGeneral nanesthetics
Chapter n26: nLocal nanesthetics
Chapter n27: nSkeletal nmuscle nrelaxants
Chapter n28: nPharmacologic nmanagement nof nparkinsonism n& nother nmovement ndisorders
Chapter n29: nAntipsychotic nagents n& nlithium
Chapter n30: nAntidepressant nagents
Chapter n31: nOpioid nagonists n& nantagonists
Chapter n32: nDrugs nof nabuse
, Section nVI: nDrugs nused nto ntreat ndiseases nof nthe nblood, ninflammation, n& ngout
Chapter n33: nAgents nused nin ncytopenias; nhematopoietic ngrowth nfactors
Chapter n34: nDrugs nused nin ndisorders nof ncoagulation
Chapter n35: nAgents nused nin ndyslipidemia
Chapter n36: nNonsteroidal nanti-inflammatory ndrugs, ndisease-modifying nantirheumatic
ndrugs, nnonopioid nanalgesics, n& ndrugs nused nin ngout
Section nVII: nEndocrine ndrugs
Chapter n37: nHypothalamic n& npituitary nhormones
Chapter n38: nThyroid n& nantithyroid ndrugs
Chapter n39: nAdrenocorticosteroids n& nadrenocortical nantagonists
Chapter n40: nThe nGonadal nhormones n& ninhibitors
Chapter n41: nPancreatic nhormones n& nantidiabetic ndrugs
Chapter n42: nAgents nthat naffect nbone nmineral nhomeostasis
Section nVIII: nChemotherapeutic ndrugs
Chapter n43: nBeta-lactam n& nother ncell nwall- n& nmembrane-active nantibiotics
Chapter n44: nTetracyclines, nmacrolides, nclindamycin, nchloramphenicol, nstreptogramins, n&
noxazolidinones
Chapter n45: nAminoglycosides n& nspectinomycin
Chapter n46: nSulfonamides, ntrimethoprim, n& nquinolones
Chapter n47: nAntimycobacterial ndrugs
Chapter n48: nAntifungal nagents
Chapter n49: nAntiviral nagents
Chapter n50: nMiscellaneous nantimicrobial nagents; ndisinfectants, nantiseptics, n& nsterilants
Chapter n51: nClinical nuse nof nantimicrobial nagents
Chapter n52: nAntiprotozoal ndrugs
Chapter n53: nClinical npharmacology nof nthe nantihelminthic ndrugs
Chapter n54: nCancer nchemotherapy
Chapter n55: nImmunopharmacology
Section nIX: nToxicology
Chapter n56: nIntroduction nto ntoxicology: noccupational n& nenvironmental
Chapter n57: nHeavy nmetal nintoxication n& nchelators
Chapter n58: nManagement nof nthe npoisoned npatient
Section nX: nSpecial ntopics
Chapter n59: nSpecial naspects nof nperinatal n& npediatric npharmacology
Chapter n60: nSpecial naspects nof ngeriatric npharmacology
Chapter n61: nDermatologic npharmacology
Chapter n62: nDrugs nused nin nthe ntreatment nof ngastrointestinal ndiseases
Chapter n63: nTherapeutic n& ntoxic npotential nof nover-the-counter nagents
Chapter n64: nDietary nsupplements n& nherbal nmedications
Chapter n65: nRational nprescribing n& nprescription nwriting
Chapter n66: nImportant ndrug ninteractions n& ntheir nmechanisms
Basic and Clinical Pharmacology by Bertram Katzung
n n n n n n
15th Edition
n
,TEST BANK
n
, Test nBank nFor nBasic nand nClinical nPharmacology n15th nEdition nby nBertram nKatzung
Table nof nContents:
Section nI: nBasic nprinciples
Chapter n1: nIntroduction: nthe nnature nof ndrugs n& ndrug ndevelopment n& nregulation
Chapter n2: nDrug nreceptors n& npharmacodynamics
Chapter n3: nPharmacokinetics n& npharmacodynamics: nrational ndosing n& nthe ntime ncourse
nof ndrug naction
Chapter n4: nDrug nbiotransformation
Chapter n5: nPharmacogenomics
Section nII: nAutonomic ndrugs
Chapter n6: nIntroduction nto nautonomic npharmacology
Chapter n7: nCholinoceptor-activating n& ncholinesterase-inhibiting ndrugs
Chapter n8: nCholinoceptor-blocking ndrugs
Chapter n9: nAdrenoceptor nagonists n& nsympathomimetic ndrugs
Chapter n10: nAdrenoceptor nantagonist ndrugs
Section nIII: nCardiovascular-renal ndrugs
Chapter n11: nAntihypertensive nagents
Chapter n12: nVasodilators n& nthe ntreatment nof nangina npectoris
Chapter n13: nDrugs nused nin nheart nfailure
Chapter n14: nAgents nused nin ncardiac narrhythmias
Chapter n15: nDiuretic nagents
Section nIV: nDrugs nwith nimportant nactions non nsmooth nmuscle
Chapter n16: nHistamine, nserotonin, n& nthe nergot nalkaloids
Chapter n17: nVasoactive npeptides
Chapter n18: nThe nEicosanoids: nprostaglandins, nthromboxanes, nleukotrienes, n& nrelated
ncompounds
Chapter n19: nNitric noxide
Chapter n20: nDrugs nused nin nasthma
Section nV: nDrugs nthat nact nin nthe ncentral nnervous nsystem
Chapter n21: nIntroduction nto nthe npharmacology nof ncns ndrugs
Chapter n22: nSedative-hypnotic ndrugs
Chapter n23: nThe nAlcohols
Chapter n24: nAntiseizure ndrugs
Chapter n25: nGeneral nanesthetics
Chapter n26: nLocal nanesthetics
Chapter n27: nSkeletal nmuscle nrelaxants
Chapter n28: nPharmacologic nmanagement nof nparkinsonism n& nother nmovement ndisorders
Chapter n29: nAntipsychotic nagents n& nlithium
Chapter n30: nAntidepressant nagents
Chapter n31: nOpioid nagonists n& nantagonists
Chapter n32: nDrugs nof nabuse
, Section nVI: nDrugs nused nto ntreat ndiseases nof nthe nblood, ninflammation, n& ngout
Chapter n33: nAgents nused nin ncytopenias; nhematopoietic ngrowth nfactors
Chapter n34: nDrugs nused nin ndisorders nof ncoagulation
Chapter n35: nAgents nused nin ndyslipidemia
Chapter n36: nNonsteroidal nanti-inflammatory ndrugs, ndisease-modifying nantirheumatic
ndrugs, nnonopioid nanalgesics, n& ndrugs nused nin ngout
Section nVII: nEndocrine ndrugs
Chapter n37: nHypothalamic n& npituitary nhormones
Chapter n38: nThyroid n& nantithyroid ndrugs
Chapter n39: nAdrenocorticosteroids n& nadrenocortical nantagonists
Chapter n40: nThe nGonadal nhormones n& ninhibitors
Chapter n41: nPancreatic nhormones n& nantidiabetic ndrugs
Chapter n42: nAgents nthat naffect nbone nmineral nhomeostasis
Section nVIII: nChemotherapeutic ndrugs
Chapter n43: nBeta-lactam n& nother ncell nwall- n& nmembrane-active nantibiotics
Chapter n44: nTetracyclines, nmacrolides, nclindamycin, nchloramphenicol, nstreptogramins, n&
noxazolidinones
Chapter n45: nAminoglycosides n& nspectinomycin
Chapter n46: nSulfonamides, ntrimethoprim, n& nquinolones
Chapter n47: nAntimycobacterial ndrugs
Chapter n48: nAntifungal nagents
Chapter n49: nAntiviral nagents
Chapter n50: nMiscellaneous nantimicrobial nagents; ndisinfectants, nantiseptics, n& nsterilants
Chapter n51: nClinical nuse nof nantimicrobial nagents
Chapter n52: nAntiprotozoal ndrugs
Chapter n53: nClinical npharmacology nof nthe nantihelminthic ndrugs
Chapter n54: nCancer nchemotherapy
Chapter n55: nImmunopharmacology
Section nIX: nToxicology
Chapter n56: nIntroduction nto ntoxicology: noccupational n& nenvironmental
Chapter n57: nHeavy nmetal nintoxication n& nchelators
Chapter n58: nManagement nof nthe npoisoned npatient
Section nX: nSpecial ntopics
Chapter n59: nSpecial naspects nof nperinatal n& npediatric npharmacology
Chapter n60: nSpecial naspects nof ngeriatric npharmacology
Chapter n61: nDermatologic npharmacology
Chapter n62: nDrugs nused nin nthe ntreatment nof ngastrointestinal ndiseases
Chapter n63: nTherapeutic n& ntoxic npotential nof nover-the-counter nagents
Chapter n64: nDietary nsupplements n& nherbal nmedications
Chapter n65: nRational nprescribing n& nprescription nwriting
Chapter n66: nImportant ndrug ninteractions n& ntheir nmechanisms
